Ligand validation:8ZRL

APR: ADENOSINE-5-DIPHOSPHORIBOSE

APR is a Ligand Of Interest in 8ZRL designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8ZRL_APR_B_402	94%	3%	0.068	0.969	5.21	1.3	13	3	2	0	100%	1
8ZRL_APR_A_402	93%	3%	0.069	0.964	5.17	1.31	13	3	5	0	100%	1
8ZRL_APR_C_402	91%	2%	0.072	0.959	5.22	1.34	13	6	2	0	100%	1
8ZRL_APR_I_402	89%	3%	0.077	0.957	5.22	1.27	13	3	5	0	100%	1
8ZRL_APR_J_402	87%	2%	0.08	0.952	5.21	1.35	13	5	2	0	100%	1
8ZRL_APR_F_402	86%	2%	0.082	0.95	5.21	1.35	12	3	4	0	100%	1
8ZRL_APR_E_402	82%	2%	0.085	0.941	5.23	1.35	13	4	2	0	100%	1
8ZRL_APR_H_402	81%	2%	0.088	0.939	5.22	1.33	13	4	2	0	100%	1
8ZRL_APR_D_402	79%	2%	0.087	0.932	5.22	1.34	12	4	4	0	100%	1
8ZRL_APR_G_402	70%	2%	0.105	0.923	5.18	1.44	13	5	6	0	100%	1
9JAV_APR_G_402	82%	64%	0.082	0.938	0.62	0.74	-	1	0	0	100%	1
8YN0_APR_A_701	100%	40%	0.032	0.995	0.72	1.6	-	6	1	0	97%	0.95
2FAV_APR_B_477	100%	36%	0.038	0.985	0.92	1.58	2	5	0	1	100%	0.97
9QYF_APR_A_501	100%	39%	0.041	0.985	0.76	1.6	1	1	0	0	100%	0.5
7R3D_APR_BBB_401	98%	66%	0.062	0.983	0.63	0.69	-	1	0	0	100%	1
3RQ6_APR_A_278	97%	38%	0.06	0.976	1.07	1.34	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.